Literature DB >> 17899094

The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis.

Nora Magdalena Torres-Carrillo1, Norma Torres-Carrillo, Mónica Vázquez-Del Mercado, Vidal Delgado-Rizo, Edith Oregón-Romero, Isela Parra-Rojas, José Francisco Muñoz-Valle.   

Abstract

We assessed whether the -844 G/A polymorphism and mRNA expression of plasminogen activator inhibitor 1 (PAI-1) gene are associated with rheumatoid arthritis (RA). Demographic data, hematological, biochemical parameters, disease activity-disability indexes, -844 G/A genotypes and mRNA expression levels of the PAI-1 gene were determined in 50 RA patients and 50 healthy subjects (HS). Non-significant differences in genotype and allele frequencies related to -844 G/A polymorphism in RA versus HS, were found. High mRNA expression of the PAI-1 gene, was demonstrated in RA versus HS (P < 0.05). In addition, A/A genotype carriers showed increase of PAI-1 mRNA expression (3.1-fold) respect to G/G and G/A genotypes in RA patients (P < 0.05). Our finding suggest an association of A/A -844 PAI-1 genotype with high PAI-1 mRNA expression in RA patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899094     DOI: 10.1007/s00296-007-0453-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

Review 1.  Physiology of cytokine pathways in rheumatoid arthritis.

Authors:  W P Arend
Journal:  Arthritis Rheum       Date:  2001-02

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.

Authors:  P E Morange; M Henry; D Tregouët; B Granel; M F Aillaud; M C Alessi; I Juhan-Vague
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

4.  Plasminogen activation in synovial tissues: differences between normal, osteoarthritis, and rheumatoid arthritis joints.

Authors:  N Busso; V Péclat; A So; A P Sappino
Journal:  Ann Rheum Dis       Date:  1997-09       Impact factor: 19.103

5.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 6.  Pivotal role of plasminogen-activator inhibitor 1 in vascular disease.

Authors:  M Agirbasli
Journal:  Int J Clin Pract       Date:  2005-01       Impact factor: 2.503

7.  Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.

Authors:  Dora Fabbro; Angela V D'Elia; Riccardo Spizzo; Lorenza Driul; Giovanni Barillari; Carla Di Loreto; Diego Marchesoni; Giuseppe Damante
Journal:  Gynecol Obstet Invest       Date:  2003-07-14       Impact factor: 2.031

Review 8.  Apoptosis as a therapeutic tool in rheumatoid arthritis.

Authors:  Richard M Pope
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

Review 9.  Plasminogen activator inhibitor-1.

Authors:  Ann Gils; Paul J Declerck
Journal:  Curr Med Chem       Date:  2004-09       Impact factor: 4.530

10.  How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI).

Authors:  M H Cardiel; M Abello-Banfi; R Ruiz-Mercado; D Alarcon-Segovia
Journal:  Clin Exp Rheumatol       Date:  1993 Mar-Apr       Impact factor: 4.473

View more
  8 in total

1.  Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis.

Authors:  Banu Bayram; Emrah Sayin; Nilüfer Erkasap; Harun Onlü; Mete Ozkurt; Fezan Sahin; Züleyha Türkoğlu
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 2.631

2.  The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

Authors:  Sun Lin; Zhang Huiya; Liu Bo; Wei Wei; Guan Yongmei
Journal:  Endocrine       Date:  2009-10-24       Impact factor: 3.633

3.  Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.

Authors:  Hye- Ok Kim; Chang- Hoon Cho; Yoon- Je Cho; Seong- Ho Cho; Kyung- Sik Yoon; Kang- Il Kim
Journal:  BMC Musculoskelet Disord       Date:  2011-07-14       Impact factor: 2.362

4.  Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children.

Authors:  Ulises De la Cruz-Mosso; José F Muñoz-Valle; Lorenzo Salgado-Goytia; Adrián García-Carreón; Berenice Illades-Aguiar; Eduardo Castañeda-Saucedo; Isela Parra-Rojas
Journal:  BMC Pediatr       Date:  2012-03-29       Impact factor: 2.125

5.  The -844 G>A PAI-1 polymorphism is associated with acute coronary syndrome in Mexican population.

Authors:  Ilian Janet García-González; Yeminia Valle; Elena Sandoval-Pinto; Emmanuel Valdés-Alvarado; Angélica Valdez-Haro; José Francisco Muñoz-Valle; Héctor Enrique Flores-Salinas; Luis Eduardo Figuera-Villanueva; Nory Omayra Dávalos-Rodríguez; Jorge Ramón Padilla-Gutiérrez
Journal:  Dis Markers       Date:  2015-02-19       Impact factor: 3.434

6.  SERPINE1 -844 and -675 polymorphisms and chronic obstructive pulmonary disease in a Chinese Han population.

Authors:  Xia Xu; Hongchao Wang; Haijun Li; Xiaopei Cui; Hongyu Zhang
Journal:  J Int Med Res       Date:  2016-11-18       Impact factor: 1.671

7.  Plasminogen activator inhibitor-1 promoter sequence variations in idiopathic osteonecrosis of head of femur.

Authors:  Srishty Raman; Rima Dada; Tapas Chandra Nag; Chandra Shekhar Yadav
Journal:  Indian J Med Res       Date:  2021-06       Impact factor: 5.274

8.  Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina.

Authors:  Sunil Kumar; Amit Kumar Verma; Vinay Sagar; Ravi Ranjan; Rahul Sharma; Preeti Tomar; Deepti Bhatt; Yamini Goyal; Mohammed A Alsahli; Ahmad Almatroudi; Saleh A Almatroodi; Arshad Husain Rahmani; Faris Alrumaihi; Khursheed Muzammil; Kapil Dev; Rakesh Yadav; Renu Saxena
Journal:  Cardiol Res Pract       Date:  2021-06-25       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.